Slush Science Pitching Finals 2017: Martti Kaasalainen
summary
Proposal uses porous silicon nanoneedles to load peptide drugs (insulin) into porous volume and deliver them via a plaster that penetrates only the outermost skin layer, avoiding nerves and pain. Claims cite 8.5% of world population with diabetes to justify scale. Labs at University of Turku handle fabrication studies of surface charge effects on peptide loading/release; a London microfabrication collaborator will test needles in vivo. System is not yet proven clinically, needs funding, IP work, and validation of loading, storage and dosing, with potential electrical control and sensing.
AI-written summary · about
related talks
11mAI Based Patent Search For Chemical Compound & Drug Discovery
45mComplexity in Living Systems
41mUsing Data Riches: A Tale of two projects
05mMaking the future
20mBuilding a Medical Device with R
08mAddressing Big Data challenges for Real time Personalized Medicine
07mDrug-Free Interventions Reverse Type 2 Diabetes
13mData Nerding in Public Health